Heidelberg Pharma AG filed its Annual on Mar 24, 2023 for the period ending Nov 30, 2022. In this report its auditor, Deloitte & Touche LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.72 EUR | -3.55% | -3.89% | -27.27% |
Apr. 25 | Heidelberg Pharma AG Reports Earnings Results for the First Quarter Ended February 29, 2024 | CI |
Apr. 23 | Transcript : Heidelberg Pharma AG - Special Call |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-27.27% | 141M | |
+14.84% | 121B | |
+18.31% | 112B | |
+2.94% | 22.72B | |
-18.26% | 20.82B | |
-18.47% | 16.66B | |
-42.36% | 16.36B | |
-14.23% | 16.19B | |
-0.68% | 13.17B | |
+21.87% | 11.11B |
- Stock Market
- Equities
- HPHA Stock
- News Heidelberg Pharma AG
- Heidelberg Pharma AG Auditor Raises 'Going Concern' Doubt